Center-Authored Papers

Filters: Author is Kiem, H P  [Clear All Filters]
Journal Article
Burtner C, Chandrasekaran D, Santos E, Beard B, Adair J, Hamlin D, Wilbur SD, Sandmaier B, Kiem H-P.  2015.  211Astatine-conjugated monoclonal CD45 antibody-based nonmyeloablative conditioning for stem cell gene therapy.. Human gene therapy. Abstract
Luche RM, Enssle J, Kiem H-P.  2012.  Abrogated cryptic activation of lentiviral transfer vectors.. Scientific reports. 2:438. Abstract
Reeves DB, Peterson CW, Kiem H-P, Schiffer JT.  2017.  Autologous stem-cell transplantation disrupts adaptive immune responses during rebound SHIV viremia.. Journal of virology. Abstract
Bonig H, Priestley GV, Wohlfahrt M, Kiem H-P, Papayannopoulou T.  2009.  Blockade of alpha6-integrin reveals diversity in homing patterns among human, baboon, and murine cells.. Stem cells and development. 18(6):839-44. Abstract
Egerer L, Kiem H-P, von Laer D.  2015.  C peptides as entry inhibitors for gene therapy.. Advances in experimental medicine and biology. 848:191-209. Abstract
Beard BC, Kiem H-P.  2009.  Canine models of gene-modified hematopoiesis.. Methods in molecular biology (Clifton, N.J.). 506:341-61. Abstract
Haworth KG, Peterson CW, Kiem H-P.  2017.  CCR5-edited gene therapies for HIV cure: Closing the door to viral entry.. Cytotherapy. Abstract
Watts KL, Delaney C, Nelson V, Trobridge GD, Beard BC, Humphries KR, Kiem H-P.  2013.  CD34(+) Expansion With Delta-1 and HOXB4 Promotes Rapid Engraftment and Transfusion Independence in a Macaca nemestrina Cord Blood Transplant Model.. Molecular therapy : the journal of the American Society of Gene Therapy. 21(6):1270-8. Abstract
Symonds G, Bartlett JS, Kiem H-P, Tsie M, Breton L.  2016.  Cell-Delivered Entry Inhibitors for HIV-1: CCR5 Downregulation and Blocking Virus/Membrane Fusion in Defending the Host Cell Population.. AIDS patient care and STDs. 30(12):545-550. Abstract
Corrigan-Curay J, Cohen-Haguenauer O, O'Reilly M, Ross SR, Fan H, Rosenberg N, Somia N, King N, Friedmann T, Dunbar C et al..  2012.  Challenges in vector and trial design using retroviral vectors for long-term gene correction in hematopoietic stem cell gene therapy.. Molecular therapy : the journal of the American Society of Gene Therapy. 20(6):1084-94.
Kiem H-P, Baum C, Bushman FD, Byrne BJ, Carter BJ, Cavagnaro J, Malech HL, Mendell JR, Naldini LM, Sorrentino BP et al..  2014.  Charting a Clear Path: The ASGCT Standardized Pathways Conference.. Molecular therapy : the journal of the American Society of Gene Therapy. 22(7):1235-8.
Trobridge GD, Wu RA, Hansen M, Ironside C, Watts KL, Olsen P, Beard BC, Kiem H-P.  2010.  Cocal-pseudotyped lentiviral vectors resist inactivation by human serum and efficiently transduce primate hematopoietic repopulating cells.. Molecular therapy : the journal of the American Society of Gene Therapy. 18(4):725-33. Abstract
Watts KL, Delaney C, Humphries KR, Bernstein ID, Kiem H-P.  2010.  Combination of HOXB4 and Delta-1 ligand improves expansion of cord blood cells.. Blood. 116(26):5859-66. Abstract
Peterson CW, Younan P, Jerome KR, Kiem H-P.  2013.  Combinatorial anti-HIV gene therapy: using a multipronged approach to reach beyond HAART.. Gene therapy. Abstract
Younan PM, Polacino P, Kowalski JP, Hu S-L, Kiem H-P.  2015.  Combinatorial hematopoietic stem cell transplantation and vaccination reduces viral pathogenesis following SHIV89.6P-challenge.. Gene therapy. 22(12):1007-1012. Abstract
Flowers MED, Inamoto Y, Carpenter PA, Lee SJ, Kiem H-P, Petersdorf EW, Pereira S, Nash RA, Mielcarek M, Fero ML et al..  2011.  Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.. Blood. 117(11):3214-9. Abstract
Bonig H, Watts KL, Chang K-H, Kiem H-P, Papayannopoulou T.  2009.  Concurrent blockade of alpha4-integrin and CXCR4 in hematopoietic stem/progenitor cell mobilization.. Stem cells (Dayton, Ohio). 27(4):836-7. Abstract
Certo MT, Gwiazda KS, Kuhar R, Sather B, Curinga G, Mandt T, Brault M, Lambert AR, Baxter SK, Jacoby K et al..  2012.  Coupling endonucleases with DNA end-processing enzymes to drive gene disruption.. Nature methods. 9(10):973-5. Abstract
Dimitrov DT, Kiem H-P, Jerome KR, Johnston C, Schiffer JT.  2016.  A curative regimen would decrease HIV prevalence but not HIV incidence unless targeted to an ART-naïve population.. Scientific reports. 6:22183. Abstract
Digiusto DL, Kiem H-P.  2012.  Current translational and clinical practices in hematopoietic cell and gene therapy.. Cytotherapy. 14(7):775-90. Abstract
Adair JE, Zhao X, Chien S, Fang M, Wohlfahrt ME, Trobridge GD, Taylor JA, Beard BC, Kiem H-P, Becker PS.  2012.  Cyclophosphamide promotes engraftment of gene-modified cells in a mouse model of Fanconi anemia without causing cytogenetic abnormalities.. Journal of molecular medicine (Berlin, Germany). 90(11):1283-1294. Abstract
Thakar MS, Bonfim C, Sandmaier BM, O'Donnell P, Ribeiro L, Gooley T, Deeg HJ, Flowers ME, Pasquini R, Storb R et al..  2012.  Cyclophosphamide-based in vivo T-cell depletion for HLA-haploidentical transplantation in Fanconi anemia.. Pediatric hematology and oncology. 29(6):568-78. Abstract
Kalina T, Lu H, Zhao Z, Blewett E, Dittmer DP, Randolph-Habecker J, Maloney DG, Andrews RG, Kiem H-P, Storek J.  2005.  De novo generation of CD4 T cells against viruses present in the host during immune reconstitution.. Blood. 105(6):2410-4. Abstract
Humbert O, Gisch DW, Wohlfahrt ME, Adams AB, Greenberg PD, Schmitt TM, Trobridge GD, Kiem H-P.  2016.  Development of 3(rd) Generation Cocal Envelope Producer Cell Lines for Robust Lentiviral Gene Transfer into Hematopoietic Stem Cells and T Cells.. Molecular therapy : the journal of the American Society of Gene Therapy. Abstract
Cowan MJ, Kiem H-P.  2016.  Devouring the Hematopoietic Stem Cell: Setting the Table for Marrow Cell Transplantation.. Molecular therapy : the journal of the American Society of Gene Therapy. 24(11):1892-1894.